News Article | December 7, 2016
Deal is first stemming from Northwell partnership with Enterprise Ireland signed Dec. 2 NEW YORK, NY--(Marketwired - December 07, 2016) - After signing an agreement on Friday that allows clients of Enterprise Ireland to supply it with innovative goods and services, Northwell Health today announced that the new partnership has already produced its first deal. New York's largest health care provider has signed an agreement with Kerry-based Salaso Health Solutions Limited to offer online care management services to patients. Northwell Health's Department of Neurology will utilize Salaso's innovative patient engagement solutions to offer online physical therapy services to victims of stroke, movement disorders and other neurological conditions. Other clinical service lines within Northwell are also in discussions with the company. "We are excited about our partnership with Salaso and believe their online physical therapy solution will enhance the quality and experience of care for our patients," said Souhel Najjar, MD, senior vice president and executive director of Northwell's Neurology Service Line, and chair and professor of neurology at the Hofstra Northwell School of Medicine. Based on evidence-based protocols, the Salaso platform uses individualized exercise videos that are prescribed by physicians, therapists, exercise physiologists, nurse practitioners and other clinicians to benefit their patients' recovery from a range of diseases and conditions. Patients report their compliance and progress through a mobile app, including their pain and effort levels, and other measures that help evaluate whether they are improving. Health care professionals are able to review patients' feedback remotely to help determine if patients are complying with the therapy and progressing in their recovery. "Having the opportunity to partner with Northwell Health, a leading U.S hospital system, has been instrumental in the international expansion of Salaso," said Aoife NiMhuiri, chief executive officer of Salaso Health Solutions. "The innovative and patient centric approach to care at Northwell Health is key to optimizing the patient engagement solutions developed by Salaso. We very much look forward to developing our relationship with Northwell Health further in 2017 and beyond." Salaso has partnered globally with panels of academic and clinical experts across many facets of health care to support research interventions in exercise prescription for multiple disease areas. The company has developed a content library of evidence-based exercises and physical activity protocols for use across multiple clinical disciplines. Salaso is the first Enterprise Ireland client to contract with Northwell Health following a ceremony on Friday at the Irish Consulate in Manhattan, where the two organizations signed a partnership agreement in the presence of Ireland Taoiseach Enda Kenny, who visited the US last week. Northwell Health is New York State's largest health care provider and private employer, with 21 hospitals and over 500 outpatient practices. We care for more than 1.8 million people annually in the metro New York area and beyond, thanks to philanthropic support from our communities. Our 61,000 employees -- including 15,000+ nurses and nearly 4,000 + doctors within Northwell Health Physician Partners -- are working to change health care for the better. We're making breakthroughs in medicine at the Feinstein Institute. We're training the next generation of medical professionals at the visionary Hofstra Northwell School of Medicine and the School of Graduate Nursing and Physician Assistant Studies. And we offer health insurance through CareConnect. For information on our more than 100 medical specialties, visit Northwell.edu. Salaso Health Solutions Limited (www.salaso.com) is a connected heath technology company providing innovative patient engagement solutions which incorporate a multimedia based clinical care management platform. Salaso's online care management platform and mobile apps support patients in building prescribed exercise routines into daily habits. Underpinned by eLearning and behavioral change principles, Salaso improves patient education and empowers patients in self-care and self-management, resulting in longer-term adherence to exercise programs and better outcomes, improving efficiency of the healthcare service being delivered. Enterprise Ireland is the Irish State agency that works with Irish enterprises to help them start, grow, innovate and win export sales in global markets. Enterprise Ireland partners with entrepreneurs, Irish businesses, and the research and investment communities to develop Ireland's international trade, innovation, leadership and competitiveness. In this way, we support sustainable economic growth and regional development, and help create and sustain employment in Ireland. www.enterprise-ireland.com
News Article | February 16, 2017
As a reflection of Northern Westchester Hospital’s (NWH) nursing professionalism, teamwork and superiority in patient care, NWH has achieved Magnet® recognition for the second time, announced by the Chair of the Commission on Magnet on Tuesday, January 31, 2017. The American Nurses Credentialing Center’s Magnet Recognition Program® distinguishes organizations that meet rigorous standards for nursing excellence. NWH achieved this recognition previously in 2012. With this credential, NWH again joins the global community of Magnet-recognized organizations. Just 448 U.S. healthcare organizations out of over 6,300 U.S. hospitals have achieved Magnet recognition. NWH is also one of nine (9) hospitals worldwide that are Planetree Designated with Distinction which means that NWH is a teaching hospital and nationally recognized leader for patient-centered care, committed to fostering patient and family engagement and creating innovative programs and services that are fundamentally attentive to the needs of patients and their families. There are currently only five (5) hospitals worldwide that are both Planetree Designated with Distinction AND Magnet recognized. “Magnet recognition provides our community with the ultimate benchmark to measure the quality of patient care,” said Lauraine Spano-Szekely, DNP, MBA, BSN, RN, Sr. Vice President Patient Care Services and Chief Nursing Officer at NWH. “Achieving Magnet recognition reinforces the culture of excellence that is a cornerstone of how we serve our community. It’s also tangible evidence of our nurses’ commitment to providing the very best quality, patient-centered care to our patients, of which we are extremely proud.” Registered Nurses at NWH are incented to obtain higher levels of education including baccalaureate preparation and certification in their specialties. Highly-qualified staff have a positive impact on patient safety. Research demonstrates that Magnet recognition provides specific benefits to health care organizations and their communities, such as: Magnet recognition is the gold standard for nursing excellence and is a factor when the public judges health care organizations. U.S. News & World Report’s annual showcase of “America’s Best Hospitals” includes Magnet recognition in its ranking criteria for quality of inpatient care. The Magnet Model provides a framework for nursing practice, research, and measurement of outcomes. Through this framework, ANCC evaluates applicants across a number of components and dimensions to gauge an organization’s nursing excellence. The foundation of this model comprises various elements deemed essential to delivering superior patient care. These include the quality of nursing leadership and coordination and collaboration across specialties, as well as processes for measuring and improving the quality and delivery of care. To achieve Magnet recognition, organizations must pass a rigorous and lengthy process that demands widespread participation from leadership and staff. This process includes an electronic application, written patient care documentation, an on-site visit, and a review by the Commission on Magnet Recognition. “We have achieved Magnet recognition on the heels of several other noteworthy achievements in 2016 that speak to the overarching quality of care and focus on patient and family engagement that can be found at Northern Westchester Hospital,” said Spano-Szekely. In addition to re-designation as a Planetree Designated Patient-Centered Hospital with Distinction, NWH received re-accreditation by the Joint Commission, and earned its fourth consecutive “A” Grade for Patient Safety in the fall 2016 Leapfrog Hospital Safety Grade. About Northern Westchester Hospital Northern Westchester Hospital (NWH), a member of the Northwell Health, provides quality, patient-centered care that is close to home through a unique combination of medical expertise, leading-edge technology, and a commitment to humanity. Over 650 highly-skilled physicians, state-of-the-art technology and professional staff of caregivers are all in place to ensure that you and your family receive treatment in a caring, respectful and nurturing environment. NWH has established extensive internal quality measurements that surpass the standards defined by the Centers for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA) National Hospital Quality Measures. Our high-quality standards help to ensure that the treatment you receive at NWH is among the best in the nation. For more information, please visit http://www.nwhc.net and connect with us on Facebook. About Northwell Health Northwell Health is New York State’s largest health care provider and private employer, with 21 hospitals and over 550 outpatient facilities. We care for more than two million people annually in the metro New York area and beyond, thanks to philanthropic support from our communities. Our 61,000 employees – 15,000+ nurses and nearly 3,400 physicians, including nearly 2,700 members of Northwell Health Physician Partners -- are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institute. We're training the next generation of medical professionals at the visionary Hofstra Northwell School of Medicine and the School of Graduate Nursing and Physician Assistant Studies. And we offer health insurance through CareConnect. For information on our more than 100 medical specialties, visit Northwell.edu. About ANCC’s Magnet Recognition Program The Magnet Recognition Program — administered by the American Nurses Credentialing Center, the largest and most prominent nurses credentialing organization in the world — identifies health care organizations that provide the very best in nursing care and professionalism in nursing practice. The Magnet Recognition Program is the highest national honor for nursing excellence and provides consumers with the ultimate benchmark for measuring quality of care. For more information about the Magnet Recognition Program and current statistics, visit http://www.nursecredentialing.org/magnet.
News Article | December 7, 2016
Bioelectronic medicine pioneer, ElectroMedical Technologies, announced its newest portable bioelectronic medicine device WellnessPro Plus for consumers and healthcare professionals to manage chronic and acute pain. WellnessPro Plus substantially enhances the WellnessPro platform by expanding the treatment modalities available in a single device. The announcement is part of the company’s aggressive plans to grow the company, attract new distributors and roll out new products during the next 12-18 months. The WellnessPro line of products represents the industry’s first intelligent portable bioelectronic therapy platform, which unlike other TENS devices, delivers faster, longer lasting pain relief based on a proprietary technology DeepPulseTM. WellnessPro is used by sports medicine, chiropractic, natural health, physiotherapy and pain management practitioners in the treatment of chronic and acute pain and is available directly from its website (http://www.electromedtech.com) or through its international network of distributors. “According to the American Academy of Pain Medicine, at least 100 million Americans suffer from chronic pain, not including acute pain for children, which translates into an annual United States healthcare cost between $560 and $635 billion,” said Mathew Wolfson, chief executive officer and founder of ElectroMedical Technologies. “Imagine a world where it were possible to treat pain using safe electrical signals, without pills and the associated side effects. That is the world we imagined more than 10 years ago, inside our mission for improving global wellness. A new era is emerging in the management of chronic illness and we feel privileged to be part of the future of medicine.” Bioelectronic medicine brings together electronics and biology for the treatment of disease and pain and is well established with pacemakers in use since the 1930’s and the first transcutaneous electrical nerve stimulation (TENS) device patented in 1974. The field has recently seen more attention with announcements such as British pharmaceutical giant GlaxoSmithKline and Google's parent company Alphabet forming a new company, Galvani Bioelectronics, to develop bioelectronic medicine devices. The increased interest in bioelectronic medicine is explained in part by the facts that an average new drug takes 10 years and $2.6 billion to get from lab to pharmacy, according to industry group PhRMA. Appearing in the Wall Street Journal, July 2016, Kevin Tracey, president and chief executive officer of the Feinstein Institute for Medical Research, commented “we live in a pharmacocentric culture today, where the world revolves around a drug for everything in a trillion-dollar pharmaceutical industry,” he says. “But when I talk to patients…people don’t want to take drugs.” According to the Feinstein Institute, “bioelectronic medicine is a scientific discipline that brings together molecular biology, neurophysiology, neurotechnology and analytics to develop nerve-stimulating technologies to regulate the molecular targets underlying disease.This approach promises to deliver therapies superior to pharmaceuticals in terms of efficacy, safety, and cost, without significant side effects.” The field of biolectronic medicine is focused on fighting diseases by delivering targeted electrical signals into the body and utilizing existing nervous-system connections linking the brain to every part of the body. ElectricalMedical’s WellnessPro platform stimulates the peripheral nerves that send information about touch and vibration. The signals from the stimulated nerves interfere with pain signals traveling to the brain which reduces the brain’s perception of pain, and stimulate naturally occurring pain relievers (e.g. dopamine). Unlike implantable bioelectronic medicine devices planned by Galvani Bioelectronics and supplied by Medtronic - among the world's largest medical technology, services and solutions companies - WellnessPro Plus is a portable device, distinguished by several important product capabilities: 1. Faster, Longer Lasting Relief. DeepPulse is a proprietary algorithm for delivering frequencies using specific rotational patterns and pulse duration to penetrate deeper into affected areas. This innovative technology prevents a known biological occurrence, referred to as accommodation, where the body adapts to specific treatments, diminishing treatment effectiveness over time. Accommodation occurs with the majority of TENS devices. 2. Broadest Treatment Application. WellnessPro Plus has the largest frequency range in its class and therefore has the broadest application for conditions that cause pain including cancer, arthritis, Parkinson’s disease, neurological disorders, spinal cord injuries, joint and back pain, among others. 3. Simple to Use. WellnessPro Plus comes pre-programmed with more than 900 ‘Autocodes’, corresponding with specific conditions (e.g. Rheumatoid Arthritis). Users simply need to enter a desired code and press Start. Autocodes are complemented by an iGuide system which walks users through all the steps required for usage when programming is required. 4. Physician Integration. StimCardTM, unique to WellnessPro bioelectronic devices, allows physicians to create, backup and store personalized patient programs with innovative capabilities and new features planned in 2017. 5. Global Certifications. FDA-cleared, European Union, ISO and HealthCanada Certified, with Mexico COFEPRIS certification pending. About ElectroMedical ElectroMedical, assembled a team of leading scientists from around the world in 2004 with a singular commitment to advancing technology for improving global wellness by relieving chronic and acute pain. In 2007, with FDA clearance, ElectroMedical delivered the world’s first intelligent portable bioelectronic medicine therapy device, WellnessPro®, which provides faster longer lasting pain relief using a unique proprietary delivery system, called DeepPulse. WellnessPro is FDA-cleared to treat chronic and acute pain and is European Union, ISO and HealthCanada certified. Today, ElectroMedical serves tens of thousands of customers across the globe and remains the innovation pioneer in portable bioelectronic devices. ElectroMedical is in the class of global leaders such as Medtronic, and helped forge a path for innovators such as Google and GlaxoSmithKline with their Galvani Bioelectronics venture. With 10 years in business, WellnessPro is the premier choice for health care professionals, athletes, coaches, medical research facilities and any individual who needs to relieve chronic or acute pain. For more information, visit http://www.electromedtech.com.
News Article | September 12, 2016
In a study published today in Nature Biotechnology, scientists from The Feinstein Institute for Medical Research and Karolinska Institutet discovered that T-cells capable of producing the neurotransmitter acetylcholine can regulate blood pressure. These T-cells are white blood cells, part of the immune system, which contain an enzyme choline acetyltransferase (ChAT). It is this ChAT enzyme that is responsible for the production of acetylcholine. Having now identified ChAT cells' new role and previously knowing that they respond to vagus nerve stimulation, Feinstein Institute researchers will explore using bioelectronic medicine to treat blood pressure and hypertension - a condition that affects more than 70 million Americans. Bioelectronic medicine is a new field of research that uses technology to treat disease and injury. "Previous studies conducted at the Feinstein Institute found that the immune function could be controlled by neural mechanisms through the spleen, and with this study we were looking to identify triggers that could reach deeper into the smaller arteries to aid with conditions such as high blood pressure," said Kevin J. Tracey, MD, president and chief executive officer of the Feinstein Institute and one of lead authors of the Nature Biotechnology paper. "We found what we were looking for, and will develop this finding into new research that we hope will pave the way to new therapies that will improve the lives of millions." Scientists from the Feinstein Institute, Karolinska Institutet in Stockholm, Sweden, University Health Network in Toronto, and York University in Toronto collaborated in making the discovery published in the Nature Biotechnology paper. Researchers at the Feinstein Institute, who are leaders in the field of bioelectronic medicine, have partnered with the Karolinska Institutet for the past 10 years. The Karolinska Institutet is one of the most-prestigious medical universities in the world and is the home of the Nobel Prize. Peder S. Olofsson, MD, PhD, worked at the Feinstein Institute between 2009 and 2015 and has since returned to the Karolinska Institute as founding director of its Center for Bioelectronic Medicine. The Feinstein Institute and Karolinska Institutet collaborate to help propel the field of bioelectronic medicine. "Interdisciplinary collaborations in bioelectronic medicine offer an opportunity to improve understanding of little understood physiological mechanisms. This study, which focusesd on blood pressure regulation, represents one such advance," said Dr. Olofsson, corresponding author of the Nature Biotechnology paper. Explore further: Feinstein to collaborate with Karolinska
News Article | November 7, 2016
Joel Seligman, President and CEO of Northern Westchester Hospital (NWH), is pleased to announce that NWH has again been formally designated by Planetree, Inc. as a “Planetree Designated® Patient-Centered Hospital with Distinction.” This designation recognizes Northern Westchester Hospital’s achievement and innovation in the delivery of patient-centered care, defined as an approach to healthcare in which providers partner with patients and families to identify and satisfy the full range of patient needs and preferences. Nine years ago, NWH was among the first organizations nationwide to achieve the designation, which is awarded for a three year term. It has since, been re-designated three times with Distinction. Today, the hospital is one of only 80 organizations worldwide to receive the Patient-Centered Hospital Designation since the program’s launch in 2007, and one of only nine organizations to be “Designated with Distinction,” and that means NWH is not only a nationally recognized leader in patient-centered care, but that NWH is also a teaching hospital for this approach to care. NWH welcomes hospitals from around the world to share best practices and has assisted numerous hospitals in replicating patient-centered care programs in their facilities. “This recognition is a direct result of Northern Westchester Hospital’s sustained excellence in patient-centered care,” said Maria Hale, Vice President, Office of Patient Advocacy and Patient Centered Services, Northern Westchester Hospital. “The Planetree Designation is the only award that recognizes excellence in person-centered care across the continuum of care,” said Susan Frampton, President of Planetree, Inc., a not-for-profit organization that has been at the forefront of the movement to transform healthcare from the perspective of the patient for almost 40 years. “The designation signals to healthcare consumers that Northern Westchester Hospital is a hospital where providers partner with patients and families, and where patient comfort, dignity, empowerment and well-being are prioritized with providing top-quality clinical care.” The criteria that a hospital must satisfy to achieve designation reflect what patients, family members and healthcare professionals in hundreds of focus groups held across the country say matters most to them during a healthcare experience. This qualitative data aligns with the growing evidence-base for patient-centered care, and establishes the Planetree Designation as a concrete framework for defining and measuring excellence in patient-centeredness. Northern Westchester Hospital is committed to creating innovative programs and services that are fundamentally attentive to the needs of patients and their families, and their feedback is used to design and implement these programs. “I am incredibly proud of our staff who strive to meet all of our patients’ needs – mind, body, and spirit – each day,” said Mr. Seligman. “High-quality patient-centered care is the cornerstone of the care we deliver at Northern Westchester Hospital, and we practice patient-centered care not only because it is the right thing to do, but because it is inextricably tied to optimal clinical outcomes for our patients.” More than 60 specific criteria address components of a patient-centered healthcare experience, including patient-provider interactions, access to information, family involvement, the physical environment, food and nutrition, spirituality, arts and entertainment, and integrative therapies. In addition, the criteria focus on how the hospital is supporting its staff, opportunities for staff, patients and families to have a voice in the way care is delivered, and the ways that the hospital is reaching beyond its walls to care for its community. Guided by these core components of a patient-centered culture, over the past 14 years, NWH has implemented a substantial number of initiatives and practices designed to enhance both the patient and staff experience. To become a Planetree Designated® Patient-Centered Hospital, Northern Westchester Hospital had to demonstrate that it has successfully implemented programs that meet the spirit and intent of the designation criteria. As part of the re-designation process — which included a site visit by representatives from Planetree — Northern Westchester Hospital was asked to demonstrate that specific patient-centered practices and policies have been sustained over time, including non-restrictive visiting hours and an open medical chart policy, widespread staff involvement in the implementation of patient-centered care, and incorporation of the patient and family perspective in hospital planning efforts. In addition, the site visit team validated that the hospital’s physical environment is a healing one engaging all of the human senses. The process also included a review of the hospital’s performance on publicly reported patient satisfaction and quality of care measures. “A strength of the designation program has been the integration of qualitative and quantitative measures,” explained Frampton. “Hospitals in the U.S. awarded designation are held accountable for exceeding benchmarks for both quality and patient satisfaction.” All designation determinations are made by an independent committee of international healthcare experts and CEOs from previously designated hospitals. About Northern Westchester Hospital Northern Westchester Hospital (NWH), a proud member of Northwell Health (formerly North Shore-LIJ Health System), provides quality, patient-centered care that is close to home through a unique combination of medical expertise, leading-edge technology, and a commitment to humanity. Over 650 highly-skilled physicians, state-of-the-art technology and professional staff of caregivers are all in place to ensure that you and your family receive treatment in a caring, respectful and nurturing environment. NWH has established extensive internal quality measurements that surpass the standards defined by the Centers for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA) National Hospital Quality Measures. Our high quality standards help to ensure that the treatment you receive at NWH is among the best in the nation. For more information, please visit http://www.nwhc.net and connect with us on Facebook. About Northwell Health Northwell Health is New York State’s largest health care provider and private employer, with 21 hospitals and over 500 outpatient practices. We care for more than 1.8 million people annually in the metro New York area and beyond, thanks to philanthropic support from our communities. Our 61,000 employees – including 15,000+ nurses and 2,500+ doctors within Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institute. We're training the next generation of medical professionals at the visionary Hofstra Northwell School of Medicine and the School of Graduate Nursing and Physician Assistant Studies. And we offer health insurance through CareConnect. For information on our more than 100 medical specialties, visit http://www.Northwell.edu. About Planetree Founded in 1978 by a patient in San Francisco, today Planetree is an internationally recognized leader in the growing movement to transform the health care experience by considering health care facilities, processes and protocols from the perspective of the patient. In diverse healthcare settings throughout the United States, Canada, Latin America, the Middle East, Asia and Europe, Planetree is demonstrating that patient-centered care is not only an empowering philosophy, but a viable, vital, and cost-effective model of care. Today, the Planetree membership network is a global community of more than 700 acute care hospitals, continuing care facilities, outpatient clinics, and consumer health libraries. The Planetree model is implemented in a variety of settings, ranging from 25-bed critical access hospitals to large urban medical centers with more than 2,000 beds.
News Article | March 1, 2017
On Sunday, April 17, more than 500 walkers are expected to support Pediatric Cancer Foundation (PCF) at its 23rd Annual Give Hope Walk in Riverside Park. Every year more than 12,000 infants and children are diagnosed with cancer. The 5K Walk is happening to help shine a light on children and teenagers living with cancer and raise funds for scientific research. The NYC Give Hope Walk is one of many fundraisers sponsored by Mamaroneck-based Pediatric Cancer Foundation. WABC-TV meteorologist Jeff Smith will be the event’s emcee. “The goal of our walk is to help raise awareness and much needed funds to fight childhood cancers,” explains Bonnie Shyer, President of the Board of Directors. “More than 2,300 children will die each year from cancer, the causes of which are still unknown, and our funding helps critical research to attack this issue.” “Hundreds of thousands of dollars have been raised over Give Hope Walk’s 23 year history,” said PCF’s Chairman of the Board, Cheryl Rosen. “We are delighted with registration thus far and know it’s going to have a huge impact on children and youth, from birth-21, who are on the front lines of the disease, and the brilliant medical minds who are the soldiers in their fight,” she added. Some of the day’s festivities include a performance by American Idol Season 14 Finalist and cancer survivor, JAX, demonstrations by the Z100 Street Team, a “guest appearance” by Ralphie the Cockapoo and a special ribbon-cutting ceremony with Westchester pediatric cancer survivors. What started out as a grassroots organization has now become a nationally-recognized nonprofit. With the inclusion of advanced technological equipment that the organization supports, PCF-funded doctors are in communication with hospitals both nationally as well as on an international level. PCF has grown to include support for children and their families afflicted with all types of cancer. More than four decades of support has enabled the foundation to purchase state-of-the-art equipment, support research projects and bring exceptional fellows to both the surgical and oncology departments. About PCF Pediatric Cancer Foundation’s mission is to find a cure for childhood cancer. Founded in 1970, this 501(c) (3) non-profit charity raises money for research, state of the art equipment/ instruments and patient/parent care for world renowned doctors at the hospitals PCF supports. These hospitals include: Columbia University Medical Center, NewYork-Presbyterian Morgan Stanley Children’s Hospital; Comer Children’s Hospital, University of Chicago; Feinstein Institute of Medical Research - Northwell Health; Maria Fareri Children’s Hospital; Memorial Sloan Kettering Cancer Center; and The Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders at NYU Langone Medical Center. The Walkathon begins at 10:00am on Sunday, April 16 at the W. 79th Boat Basin Rotunda in Riverside Park. To register online, please visit pcfwalk.org/register/ or contact Nancy Joselson at 914-777-3127.
News Article | February 21, 2017
NEW YORK, Feb. 21, 2017 /PRNewswire-USNewswire/ -- Northwell Health's Feinstein Institute for Medical Research today announced a strategic alliance with GE Ventures to support the Feinstein's Center for Bioelectronic Medicine (CBEM). With this investment, the Feinstein Institute will...
News Article | November 8, 2016
Pediatric Cancer Foundation (PCF), the 46 year-old, Mamaroneck-based nonprofit committed to fighting pediatric cancer, hosted its Rock The Cure Gala at Brae Burn Country Club in Purchase, New York on November 2nd. The evening drew more than 250 attendees and featured legendary rock music by Unforgettable Fire, a world-renowned U2 cover band. The gala raised $225,000 to support research, state of the art equipment/instruments and patient/parent care for doctors at the hospitals PCF supports. This year’s event was in memory of Paul Ulysses Jimenez, a 10-year-old Westchester County boy who passed away in January, 2016, from Rhabdomyosarcoma (RMS), a rare form of cancer of the skeletal muscles. “Our amazing little boy taught us so much about life, about love and about strength,” remarked Paul Jimenez, Sr. in his keynote speech. “This week will mark 10 months since we have been able to kiss Paul and tell him how much we love him. I implore each and every one of you to please spread awareness for pediatric cancer research. We need to find a cure and our dream is to one day see that cure happen.” “It was an incredibly moving night,” exclaimed Bonnie Shyer, PCF president. “We listened with our hearts as Paul Jimenez spoke about his son and losing him to this horrible disease. We danced in celebration of a little boy’s life and the joy he brought to others, as well as the thousands of children and families fighting this battle. And, most importantly, we raised critical funds needed by the generosity of our steadfast supporters.” What started out as a small, local organization has now become a nationally-recognized nonprofit. With the inclusion of advanced technological equipment that the organization supports, PCF-funded doctors are in communication with hospitals both nationally as well as on an international level. PCF has grown to include support for children and their families afflicted with all types of cancer. Four decades of support has enabled the foundation to purchase state-of-the-art equipment, support research projects and bring exceptional fellows to both surgical and oncology departments across the country. County Executive Robert Astorino attended the gala, stating, “PCF started here in Westchester 46 years ago and is still going strong. Thank you for all you are doing." Noting the moving story of young Paul Jimenez's life, he went on to say, "We're here tonight to help families down the line, so that they may never have to experience something like this.” About PCF PCF’s mission is to find a cure for childhood cancer. The 501(c) (3) nonprofit raises money for research, state of the art equipment/ instruments and patient/parent care for world-renowned doctors at the hospitals PCF supports. These hospitals include: NewYork-Presbyterian Morgan Stanley Children’s Hospital, Memorial Sloan-Kettering Cancer Center, Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders at NYU Langone Medical Center, Feinstein Institute of Medical Research - Northwell Health, Maria Fareri Children’s Hospital at Westchester Medical Center and Comer Children’s Hospital, The University of Chicago Medicine & Biological Sciences. For more information about Pediatric Cancer Foundation, please visit http://www.pcfweb.org/ or contact Nancy Joselson at 914-777-3127.
Tracey K.J.,Feinstein Institute
Cell | Year: 2016
Simple reflex circuits provide crucial infrastructure for the neurological control of organ systems - even the immune system. Now, Gabanyi et al. reveal a reflex mechanism in gut activated by the presence of pathogens that forces macrophages into a tissue protective phenotype. © 2016 Elsevier Inc.
News Article | July 7, 2016
Zika Virus - What You Should Know Ticked Off! Here's What You Need To Know About Lyme Disease A new study has found that rheumatoid arthritis patients who received vagus nerve stimulation showed "robust" responses. The treatment involved an implantation of a device designed to stimulate the vagus nerve. The experiment was conducted at the Feinstein Institute for Medical Research. In this autoimmune disease, the immune system attacks the joints. While the actual cause of rheumatoid arthritis remains unknown, treatments are designed to stop the resulting inflammations, which then relieves the symptoms, reduces long-term difficulties and prevents severe injury. A team of researchers from the Feinstein Institute, SetPoint Medical and the University of Amsterdam conducted a study to see if a direct inflammatory reflex stimulation can reduce rheumatoid arthritis symptoms. Prior studies of the method conducted on animals already showed success rates. The findings of the recent experiment showed that the method could also work in humans. Moreover, the treatment concept can be effective in treating other forms of inflammatory diseases. Feinstein Institute president and CEO Kevin Tracey said that the study is a "real breakthrough" in the ability to help patients with inflammatory diseases. Tracey added that until the study, there was no evidence that electrically stimulating the vagus nerve can prevent the production of cytokine and reduce the disease's severity in human patients. The findings can change the way the scientific and medical communities see modern medicine and deepen our understanding of what the nerves can do. For instance, with a little help, the nerves can make the "drugs" needed to help the body repair itself. For the study, the research team enrolled 17 patients whose vagus nerve was surgically given a stimulation device. Working on a schedule, the implanted device activated and deactivated the vagus nerve for a total of 84 days. The rate of response and progress were measured for 42 days. The patient's response to the stimulation device was measured using the standard DAS28-CRP scoring system, which includes measurements for swollen and tender joints, levels of serum C-reactive protein (CRP) as well as the evaluations made by both patients and physicians. The research team noted there were no dangerous side effects documented in any patient. Moreover, many of the patients whose previous treatments failed showed significant developments. "Our findings suggest a new approach to fighting diseases with bioelectronic medicines," said SetPoint Medical chief executive officer Anthony Arnold. The new method makes use of electrical pulses to treat medical conditions that are currently using strong and costly drugs. The findings were published in the journal Proceedings of the National Academy of Sciences. © 2017 Tech Times, All rights reserved. Do not reproduce without permission.